ZENAS BIOPHARMA INC (ZBIO) Stock Earnings & Estimates
USA - NASDAQ:ZBIO - US98937L1052 - Common Stock
21.76 USD
+0.81 (+3.87%)
21.76 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 50M | 5M -90.00% | 10.2M 104.00% | 20.836M 104.27% | 47.132M 126.20% | ||
| EBITDA YoY % growth | -75.121M | -27.034M 64.01% | -163.751M -505.72% | -203.365M -24.19% | -255.524M -25.65% | -292.943M -14.64% | |
| EBIT YoY % growth | -75.199M | -27.147M 63.90% | -163.888M -503.71% | -178.362M -8.83% | -226.337M -26.90% | -256.757M -13.44% | |
| Operating Margin | N/A | -54.29% | -3,277.76% | -1,748.65% | -1,086.28% | -544.76% | |
| EPS YoY % growth | N/A | N/A | N/A | -3.56 52.30% | -4.47 -25.40% | -3.77 15.63% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.69 86.23% | -0.75 81.10% | -1.23 -54.08% | -1.24 0.86% | -1.14 -64.98% | -1.09 -44.69% | -1.18 4.01% | -1.13 8.72% | -0.97 15.12% | -0.93 14.91% |
| Revenue Q2Q % growth | -100.00% | -100.00% | 2.193M | 1.624M | 5.328M | 10.779M | 18.297M 734.34% | |||
| EBITDA Q2Q % growth | -59.073M -44.50% | -62.027M -11.79% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -54.727M -33.53% | -57.265M -2.95% | -56.814M -52.19% | -57.324M -3.92% | -58.242M -6.42% | -60.384M -5.45% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.25 | -1.07 | -0.18 | -16.71% |
| Q1 2025 Q2Q % growth | -0.80 | -1.13 | 0.33 | 29.34% |
| Q4 2024 Q2Q % growth | -3.99 | -1.02 | -2.97 | -290.79% |
| Q3 2024 Q2Q % growth | -5.02 | -9.51 | 4.49 | 47.24% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.275M | -1.275M | -100.00% | |
| Q1 2025 Q2Q % growth | 10M | 1.7M | 8.3M | 488.24% |
| Q3 2024 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 44.35% | 29.23% | 21.92% | 15.72% |
| Revenue | N/A | -100% | 0% | -33.33% |